GS TEW 50 mg Pill - red capsule/oblong
Generic Name: dabrafenib
Pill with imprint GS TEW 50 mg is Red, Capsule/Oblong and has been identified as Tafinlar 50 mg. It is supplied by GlaxoSmithKline.
Tafinlar is used in the treatment of Melanoma, Metastatic; Thyroid Cancer; Non-Small Cell Lung Cancer; Solid Tumors; Low-Grade Glioma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS TEW 50 mg
Tafinlar
- Generic Name
- dabrafenib
- Imprint
- GS TEW 50 mg
- Strength
- 50 mg
- Color
- Red
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
hypromelloses,
ferric oxide red,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0846 (Discontinued) | GlaxoSmithKline |
| 00078-0682 | Novartis Pharmaceuticals Corporation |
More about Tafinlar (dabrafenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
